In their meticulous investigation, Cox et al. thoroughly assessed IR and IGF-1R expression levels in tissue samples obtained from patients with prostate cancer, comparing them to samples collected from normal prostate tissues. This evidence concerns the gene INSR and prostate carcinoma.